Brulin B, Nolan JC, Marangon T et al (2021) Evaluation of the chemotherapy drug response using organotypic cultures of osteosarcoma tumours from mice models and canine patients. Cancers (basel) 13(19):4890

Article  CAS  PubMed  Google Scholar 

Cai X, Xiao W, Shen J et al (2020) Thiostrepton and miR-216b synergistically promote osteosarcoma cell cytotoxicity and apoptosis by targeting FoxM1. Oncol Lett 20(6):391

Article  PubMed  PubMed Central  Google Scholar 

Chen X, Zhang Q, Dang X et al (2021) Targeting the CtBP1-FOXM1 transcriptional complex with small molecules to overcome MDR1-mediated chemoresistance in osteosarcoma cancer stem cells. J Cancer 12(2):482–497

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dey H, Vasudevan K, Doss CGP et al (2023) Integrated gene network analysis sheds light on understanding the progression of Osteosarcoma. Front Med (lausanne) 10:1154417

Article  PubMed  Google Scholar 

Dowless M, Lowery CD, Shackleford T et al (2018) Abemaciclib is active in preclinical models of Ewing sarcoma via multipronged regulation of cell cycle, DNA methylation, and interferon pathway signaling. Clin Cancer Res 24(23):6028–6039

Article  CAS  PubMed  PubMed Central  Google Scholar 

Han X, Liu F, Zhang C et al (2019) SIAH1/ZEB1/IL-6 axis is involved in doxorubicin (Dox) resistance of osteosarcoma cells. Biol Chem 400(4):545–553

Article  CAS  PubMed  Google Scholar 

Han T, Wu Z, Zhang Z et al (2023) Comprehensive analysis of hypoxia-related genes for prognosis value, immune status, and therapy in osteosarcoma patients. Front Pharmacol 13:1088732

Article  PubMed  PubMed Central  Google Scholar 

He L, Yang H, Huang J (2021) The tumor immune microenvironment and immune-related signature predict the chemotherapy response in patients with osteosarcoma. BMC Cancer 21(1):581

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hu K, Xie W, Ni S et al (2020) Cadmium chloride enhances cisplatin sensitivity in osteosarcoma cells by reducing FOXM1 expression. Oncol Rep 44(2):650–660

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hu L, Wu X, Chen D et al (2022) The hypoxia-related signature predicts prognosis, pyroptosis and drug sensitivity of osteosarcoma. Front Cell Dev Biol 10:814722

Article  PubMed  PubMed Central  Google Scholar 

Kim H, Yoo S, Zhou R et al (2018) Oncogenic role of SFRP2 in p53-mutant osteosarcoma development via autocrine and paracrine mechanism. Proc Natl Acad Sci USA 115(47):E11128–E11137

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li Y, Zhang T, Zhang Y et al (2018) Targeting the FOXM1-regulated long noncoding RNA TUG1 in osteosarcoma. Cancer Sci 109(10):3093–3104

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li Y, Wang Z, Li J et al (2019) Diallyl disulfide suppresses FOXM1-mediated proliferation and invasion in osteosarcoma by upregulating miR-134. J Cell Biochem 120(5):7286–7296

Article  CAS  PubMed  Google Scholar 

Li Z, Li H, Chen J et al (2020a) SPAG5 promotes osteosarcoma metastasis via activation of FOXM1/MMP2 axis. Int J Biochem Cell Biol 126:105797

Article  CAS  PubMed  Google Scholar 

Li Z, Yu DS, Doetsch PW et al (2020b) Replication stress and FOXM1 drive radiation induced genomic instability and cell transformation. PLoS ONE 15(11):e0235998

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lv Y, Wu L, Jian H et al (2022) Identification and characterization of aging/senescence-induced genes in osteosarcoma and predicting clinical prognosis. Front Immunol 13:997765

Article  CAS  PubMed  PubMed Central  Google Scholar 

Pan R, Pan F, Zeng Z et al (2022) A novel immune cell signature for predicting osteosarcoma prognosis and guiding therapy. Front Immunol 13:1017120

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ren Z, Hu Y, Sun J et al (2022) N6-methyladenosine methyltransferase WTAP-stabilized FOXD2-AS1 promotes the osteosarcoma progression through m6A/FOXM1 axis. Bioengineered 13(4):7963–7973

Article  CAS  PubMed  PubMed Central  Google Scholar 

Shen B, Zhou N, Hu T et al (2019) LncRNA MEG3 negatively modified osteosarcoma development through regulation of miR-361-5p and FoxM1. J Cell Physiol 234(8):13464–13480

Article  CAS  PubMed  Google Scholar 

Shi D, Mu S, Pu F et al (2022) Integrative analysis of immune-related multi-omics profiles identifies distinct prognosis and tumor microenvironment patterns in osteosarcoma. Mol Oncol 16(11):2174–2194

Article  CAS  PubMed  PubMed Central  Google Scholar 

Su Z, Wang C, Pan R et al (2022) The hexosamine biosynthesis pathway-related gene signature correlates with immune infiltration and predicts prognosis of patients with osteosarcoma. Front Immunol 13:1028263

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sun Y, Jia X, Wang M et al (2019) Long noncoding RNA MIR31HG abrogates the availability of tumor suppressor microRNA-361 for the growth of osteosarcoma. Cancer Manag Res 11:8055–8064

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang W, Guo Z, Yu H et al (2019a) MiR-216b inhibits osteosarcoma cell proliferation, migration, and invasion by targeting Forkhead Box M1. J Cell Biochem 120(4):5435–5443

Article  CAS  PubMed  Google Scholar 

Wang L, Liu Y, Yu G (2019b) Avasimibe inhibits tumor growth by targeting FoxM1-AKR1C1 in osteosarcoma. Onco Targets Ther 12:815–823

Article  PubMed  PubMed Central  Google Scholar 

Xu F, Yan J, Peng Z et al (2022) Comprehensive analysis of a glycolysis and cholesterol synthesis-related genes signature for predicting prognosis and immune landscape in osteosarcoma. Front Immunol 13:1096009

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yang M, Zheng H, Xu K et al (2022) A novel signature to guide osteosarcoma prognosis and immune microenvironment: cuproptosis-related lncRNA. Front Immunol 13:919231

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhang W, Duan N, Zhang Q et al (2017) DNA methylation mediated down-regulation of miR-370 regulates cell growth through activation of the Wnt/β-catenin signaling pathway in human osteosarcoma cells. Int J Biol Sci 13(5):561–573

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhang H, Zhou Q, Shen W (2022) Circ-FOXM1 promotes the proliferation, migration and EMT process of osteosarcoma cells through FOXM1-mediated Wnt pathway activation. J Orthop Surg Res 17(1):344

Article  PubMed  PubMed Central  Google Scholar 

Zhang Z, Zhu Z, Fu J et al (2023) Anoikis patterns exhibit distinct prognostic and immune landscapes in Osteosarcoma. Int Immunopharmacol 115:109684

Article  CAS  PubMed  Google Scholar 

Zhu X, Lu K, Cao L et al (2020) FoxM1 is upregulated in osteosarcoma and inhibition of FoxM1 decreases osteosarcoma cell proliferation, migration, and invasion. Cancer Manag Res 12:9857–9867

Article  CAS  PubMed  PubMed Central  Google Scholar